Sites of in vivo phosphorylation of the T cell tyrosine protein kinase in LSTRA cells and their alteration by tumor-promoting phorbol esters - PubMed (original) (raw)
. 1987 Jul 15;262(20):9859-64.
- PMID: 3496339
Free article
Sites of in vivo phosphorylation of the T cell tyrosine protein kinase in LSTRA cells and their alteration by tumor-promoting phorbol esters
J E Casnellie. J Biol Chem. 1987.
Free article
Abstract
The LSTRA cell line contains an elevated level of a tyrosine protein kinase of apparent molecular weight of 56,000 (pp56Tcell). Analysis of the tryptic fragments of this protein labeled in vivo with 32P shows that it contains four sites of tyrosine phosphorylation and one site of serine phosphorylation. Two of the sites of in vivo tyrosine phosphorylation are also labeled in vitro when membranes are incubated with [gamma-32P]ATP. One of the sites that is labeled in vivo and in vitro (site 1) is identical in sequence with the major site of tyrosine phosphorylation in the transforming protein of the Rous sarcoma virus. Analysis of the sites of in vivo phosphorylation in pp56Tcell from LSTRA cells treated with 4 beta-phorbol 12 beta-myristate 13 alpha-acetate (PMA) reveals that this agent induces at least four new sites of serine phosphorylation. Treatment with PMA also causes a selective reduction in the level of tyrosine phosphorylation in site 1. Thus PMA causes new sites of serine phosphorylation in pp56Tcell and reduces the amount of phosphate in one of the sites of tyrosine phosphorylation.
Similar articles
- Anti-CD3 and phorbol ester induce distinct phosphorylated sites in the SH2 domain of p56lck.
Soula M, Rothhut B, Camoin L, Guillaume JL, Strosberg D, Vorherr T, Burn P, Meggio F, Fischer S, Fagard R. Soula M, et al. J Biol Chem. 1993 Dec 25;268(36):27420-7. J Biol Chem. 1993. PMID: 8262984 - Alterations in expression of p56lck during myeloid differentiation of LSTRA cells.
Garcia-Welsh A, Laskin DL, Molloy CJ, Laskin JD. Garcia-Welsh A, et al. Cell Growth Differ. 1994 Nov;5(11):1215-23. Cell Growth Differ. 1994. PMID: 7531490 - Regulation of insulin receptor kinase by multisite phosphorylation.
Yu KT, Pessin JE, Czech MP. Yu KT, et al. Biochimie. 1985 Oct-Nov;67(10-11):1081-93. doi: 10.1016/s0300-9084(85)80105-x. Biochimie. 1985. PMID: 3000458
Cited by
- Modulating p56Lck in T-Cells by a Chimeric Peptide Comprising Two Functionally Different Motifs of Tip from Herpesvirus saimiri.
Vernot JP, Perdomo-Arciniegas AM, Pérez-Quintero LA, Martínez DF. Vernot JP, et al. J Immunol Res. 2015;2015:395371. doi: 10.1155/2015/395371. Epub 2015 Oct 11. J Immunol Res. 2015. PMID: 26539553 Free PMC article. - Phosphorylation of Ser-42 and Ser-59 in the N-terminal region of the tyrosine kinase p56lck.
Winkler DG, Park I, Kim T, Payne NS, Walsh CT, Strominger JL, Shin J. Winkler DG, et al. Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):5176-80. doi: 10.1073/pnas.90.11.5176. Proc Natl Acad Sci U S A. 1993. PMID: 8506364 Free PMC article. - The protein tyrosine kinase p56lck regulates cell adhesion mediated by CD4 and major histocompatibility complex class II proteins.
Kinch MS, Sanfridson A, Doyle C. Kinch MS, et al. J Exp Med. 1994 Nov 1;180(5):1729-39. doi: 10.1084/jem.180.5.1729. J Exp Med. 1994. PMID: 7964457 Free PMC article. - Neoplastic transformation induced by an activated lymphocyte-specific protein tyrosine kinase (pp56lck).
Marth JD, Cooper JA, King CS, Ziegler SF, Tinker DA, Overell RW, Krebs EG, Perlmutter RM. Marth JD, et al. Mol Cell Biol. 1988 Feb;8(2):540-50. doi: 10.1128/mcb.8.2.540-550.1988. Mol Cell Biol. 1988. PMID: 3352600 Free PMC article. - Alterations of the lymphocyte-specific protein tyrosine kinase (p56lck) during T-cell activation.
Veillette A, Horak ID, Horak EM, Bookman MA, Bolen JB. Veillette A, et al. Mol Cell Biol. 1988 Oct;8(10):4353-61. doi: 10.1128/mcb.8.10.4353-4361.1988. Mol Cell Biol. 1988. PMID: 3141789 Free PMC article.